tiprankstipranks
Syros Pharmaceuticals (SYRS)
NASDAQ:SYRS

Syros Pharmaceuticals (SYRS) Financial Statements

863 Followers

Syros Pharmaceuticals Financial Overview

Syros Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-5.766; its P/E ratio is -1.01; Syros Pharmaceuticals is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.78. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 387.00K$ 3.76M$ 2.83M$ 2.95M$ -754.00K
Gross Profit$ 387.00K$ 3.76M$ 2.83M$ 2.95M$ -754.00K
EBIT$ -63.02M$ -38.89M$ -34.98M$ -22.57M$ -5.28M
EBITDA$ -62.47M$ -38.28M$ -34.82M$ -22.33M$ -4.33M
Net Income Common Stockholders$ -64.38M$ -40.14M$ -36.26M$ -23.79M$ -4.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 139.53M$ 112.22M$ 143.98M$ 165.80M$ 202.30M
Total Assets$ 168.17M$ 147.79M$ 180.98M$ 205.32M$ 244.49M
Total Debt$ 62.08M$ 62.46M$ 62.83M$ 63.17M$ 63.57M
Net Debt$ -77.45M$ -49.76M$ -81.16M$ -102.63M$ -138.73M
Total Liabilities$ 151.51M$ 111.49M$ 107.74M$ 98.57M$ 116.75M
Stockholders Equity$ 16.66M$ 36.30M$ 73.22M$ 106.75M$ 127.74M
Cash Flow-
Free Cash Flow$ -17.04M$ -31.86M$ -22.39M$ -37.14M$ -31.76M
Operating Cash Flow$ -18.56M$ -31.86M$ -22.39M$ -36.90M$ -31.08M
Investing Cash Flow$ 1.52M$ 28.64M$ 32.92M$ -25.75M$ 37.72M
Financing Cash Flow$ 43.38M$ -5.00K$ 140.00K$ -53.00K$ -10.70M
Currency in USD

Syros Pharmaceuticals Earnings and Revenue History

Syros Pharmaceuticals Debt to Assets

Syros Pharmaceuticals Cash Flow

Syros Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis